401(k) · DOL Form 5500 · 2022
Ipsen Biopharmaceuticals, Inc 401(k) Plan
Data updated 2026-08-11
- $125M
- Total assets
- 505
- Participants
- 94th
- Percentile by assets
- $247,567
- Avg per participant
Official DOL plan name: Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan · Sponsored by Ipsen Biopharmaceuticals, Inc · New Jersey · Wholesale Trade
$125M in assets, 505 participants
Ipsen Biopharmaceuticals, Inc's Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported $125M in total assets and 505 participants in its 2022 DOL Form 5500 filing, ranking in the 94th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.
- 94th percentile by assets (of 139,126 plans)
- #6,511 in Wholesale Trade (6,843 peers)
Where Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits by assets
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits in the top 10% of all filed plans by assets, $125M for 505 participants (~$247,567/participant), down 7.3% in 2022.
- $125M
- total plan assets (2022 EOY)
- 505
- covered participants
- 94th
- percentile by assets (of 139,126 plans)
- $247,567
- avg assets per participant
The plan reported a net loss of $10M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs the 2022 asset distribution
By assets, Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan outranks 94% of the 139,126 plans that filed a Form 5500 for the 2022 plan year, and holds roughly 1.3x the national average plan size of $100M (721 average participants).
Scale-class filing particulars (2022)
| Total Assets (Beginning of Year) | $135M |
|---|---|
| Net Assets (End of Year) | $125M |
| Net Income | -$10M |
| Employer EIN | 260042539 |
| Plan Effective Date | 2005-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (Ipsen Biopharmaceuticals, Inc)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 505 | $125M |
| 2023 | 1 | 622 | $166M |
| 2024 | 1 | 692 | $206M |
Nearby 401(k) Plans in New Jersey
Peer 401(k) plans, same state, same plan type, ranked by total assets.
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs. nearby 401(k) plans in New Jersey, assets vs. participants
- JPMorgan Chase 401(k) Savings Plan $36.8B · 168,280
- Verizon Savings Plan for Management Employees $25.2B · 76,788
- Johnson and Johnson Savings Plan $21.2B · 43,271
- Pfizer Savings Plan $17.8B · 27,796
- Ernst & Young Retirement Savings Plan $12.4B · 52,975
Similar-Sized 401(k) Plans Nationally
401(k) plans in other states closest to Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan by total assets, not by location.
- Neogenomics Laboratories, Inc. 401(k) Profit Sharing Plan (FL) $125M · 2,035
- Continental Mills, Inc. 401 (K) Retirement Savings Plan (WA) $125M · 792
- Project Worldwide 401(k) Plan (MI) $125M · 1,330
- Tower Semiconductor Newport Beach Retirement Savings Plan (CA) $125M · 1,065
Frequently Asked Questions
How did Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan assets move in 2022? ▼
How have Ipsen Biopharmaceuticals, Inc plan assets changed over time? ▼
Where does Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan rank by assets among Form 5500 filers? ▼
Which 401(k) plans are similar in size to Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan? ▼
Next read for Ipsen Biopharmaceuticals, Inc. U.S. 401(…
Scale reading
Ways to act on Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan's numbers.
- By total assets, Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan ranks in the top 10% of all filed plans by assets. See the largest plans
- Compare it side-by-side against 3 similar 401(k) plans in New Jersey. Compare plans
- Ipsen Biopharmaceuticals, Inc's sponsor-wide assets have grown 64.6% since 2022 across 3 plan years on file. More Wholesale Trade plans